News

HealthCare Institute of New Jersey Statement on the Patient and Provider Protection Act and PBM Reform

Trenton, March 19, 2026 ― Chrissy Buteas, President and Chief Executive Officer of the HealthCare Institute of New Jersey (HINJ – www.hinj.org), released the following statement concerning today’s Assembly Financial Institutions and Insurance Committee’s hearing on Chairman Roy Freiman’s “Patient and Provider Protection Act.”

“HINJ commends Chairman Freiman and the AFI Committee for their steadfast work to lower costs for patients while preserving future advances in human health.  As the ‘Medicine Chest of the World,’ New Jersey’s global leadership in medicine and innovation starts with smart policies that expand patient access.”

Buteas continued, “As we’ve said, less than half of the money spent on prescription medicines goes to the company that makes the medicine – the rest goes to PBMs and other middlemen, and there are even more ways PBM policies can be reformed to lower costs.  We look forward to working with the Committee, the bill sponsors, and other stakeholders to enact these and other proposals to benefit New Jersey patients.”